AGIO - CIK 0001439222
The table below shows AGIOS PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $113.60M | $92.71M | $80.87M | $78.96M | $253.73M | $84.52M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $35.09M | $32.03M | $30.85M | $29.61M | $26.43M | $23.94M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $834.84M |
| $1.03B |
| $1.02B |
| $968.62M |
| $1.07B |
| $632.13M |
| Property, plant & equipment | $10.57M | $10.68M | $10.58M | $11.07M | $11.82M | $12.73M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.18B | $1.39B | $1.47B | $1.56B | $1.79B | $773.06M |
| Accounts payable | $13.75M | $19.55M | $17.53M | $13.73M | $17.14M | $10.04M |
| Total current liabilities | $58.84M | $74.76M | $70.41M | $52.37M | $119.45M | $62.64M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $75.88M | $101.38M | $101.68M | $88.99M | $165.12M | $112.55M |
| Retained earnings | -$660.82M | -$453.67M | -$350.23M | -$238.21M | -$52.40M | -$1.00B |
| Total equity | $1.11B | $1.28B | $1.37B | $1.47B | $1.63B | $660.51M |